Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,205Revenue (TTM) $M--Net Margin (%)--Altman Z-Score--
Enterprise Value $M2,205EPS (TTM) $2.0Operating Margin %--Piotroski F-Score5
P/E(ttm)11.4Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yY
Price/Free Cash Flow13.6y-y EBITDA Growth Rate %--ROA % (ttm)13.0Higher Current Ratio y-yN
Dividend Yield %5.8PEG--ROE % (ttm)13.0Less Shares Outstanding y-yY
Payout Ratio %66.0Shares Outstanding M94.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABMario Gabelli 2016-09-30 Reduce$21.34 - $24.6
($22.62)
$ 23.102%Reduce -0.87%244,898
ABMario Gabelli 2016-06-30 Reduce$21.56 - $24.47
($23.31)
$ 23.10-1%Reduce -5.76%247,046
ABMario Gabelli 2016-03-31 Reduce$16.8 - $23.85
($20.29)
$ 23.1014%Reduce -0.40%262,146
ABMario Gabelli 2015-12-31 Reduce$21.41 - $27.41
($25.19)
$ 23.10-8%Reduce -6.80%263,196
ABMario Gabelli 2015-09-30 Reduce$25.18 - $29.55
($27.43)
$ 23.10-16%Reduce -3.68%282,396
ABMario Gabelli 2015-06-30 Reduce$29.1 - $32.4
($31.05)
$ 23.10-26%Reduce -1.87%293,196
ABMario Gabelli 2015-03-31 Reduce$24.16 - $30.93
($27.19)
$ 23.10-15%Reduce -3.26%298,796
ABMario Gabelli 2014-12-31 Reduce-0.03%$22.95 - $27.24
($25.61)
$ 23.10-10%Reduce -40.75%308,871
ABRonald Muhlenkamp 2014-09-30 Buy 0.05%$25.15 - $27.76
($26.78)
$ 23.10-14%New holding11,550
ABRonald Muhlenkamp 2014-06-30 Sold Out -0.05%$22.99 - $26.41
($24.94)
$ 23.10-7%Sold Out0
ABRonald Muhlenkamp 2014-03-31 Reduce-0.01%$21.07 - $25.77
($23.34)
$ 23.10-1%Reduce -25.19%11,550
ABRonald Muhlenkamp 2013-12-31 Buy 0.06%$19.5 - $22.78
($21.51)
$ 23.107%New holding15,440
ABMario Gabelli 2011-03-31 Reduce-0.07%$20.71 - $24.11
($22.17)
$ 23.104%Reduce -48.16%430,940
ABCharles Brandes 2011-03-31 Sold Out $20.71 - $24.11
($22.17)
$ 23.104%Sold Out0
ABWhitney Tilson 2010-06-30 Sold Out -0.14%$26.64 - $33.76
($30.08)
$ 23.10-23%Sold Out0
ABMario Gabelli 2010-06-30 Reduce-0.02%$26.64 - $33.76
($30.08)
$ 23.10-23%Reduce -22.53%661,100
ABRon Baron 2010-03-31 Sold Out $25.07 - $30.55
($28)
$ 23.10-18%Sold Out0
ABKeeley Asset Management Corp 2009-12-31 Sold Out -0.01%$24.52 - $28.73
($26.72)
$ 23.10-14%Sold Out0
ABRon Baron 2009-12-31 Reduce$24.52 - $28.73
($26.72)
$ 23.10-14%Reduce -61.75%10,262
ABRon Baron 2009-09-30 Reduce-0.01%$18 - $27.22
($22.2)
$ 23.104%Reduce -67.97%26,832
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HICKS WESTON MDirector 2016-08-04Sell4,539$21.57.44view
HICKS WESTON MDirector 2016-08-04Sell4,539$21.57.44view
FARRELL EDWARD JSVP and Controller 2016-06-08Sell5,000$23.61-2.16view
SCHOEN SCOTT ADirector 2016-05-20Buy11,500$23.090.04view
HICKS WESTON MDirector 2016-05-10Sell10,842$23.36-1.11view
van Brugge Robert PChairman and CEO, SCB LLC 2016-05-04Sell30,595$23.030.3view
FARRELL EDWARD JSVP and Controller 2015-06-12Sell5,000$31.1-25.72view
HICKS WESTON MDirector 2014-10-27Sell5,000$25.8-10.47view
Weisenseel John CSVP and CFO 2012-05-14Sell0$0-10.47view
Molloy KevinDirector 2011-01-26Sell0$0-10.47view

Quarterly/Annual Reports about AB:

News about AB:

Articles On GuruFocus.com
What I Don’t Want as a Dividend Growth Investor Sep 09 2016 
Five Cheap Stocks with Improving Earnings Mar 02 2016 
Royce Total Return Fund's Semiannual Letter to Shareholders Sep 16 2015 
A Look at Why International Markets are a Better Buy than the U.S. Market Nov 24 2014 
My 4 Favorite Stocks With Recent Dividend Growth Aug 04 2013 
20 of the Best Dividend-Paying Asset Management Stocks Feb 25 2013 
65 Stocks and Funds Increased Dividends Last Week Feb 18 2013 
My 4 Favorite Picks From Last Week's Dividend Growth Stocks Oct 29 2012 
The Best Stocks With Dividend Growth From Last Week (April 30 – May 06, 2012) May 06 2012 
AllianceBernstein Holding L.P. Units Reports Operating Results (10-K) Feb 10 2011 

More From Other Websites
More Investors Plan To Buy ETFs in 2017, BlackRock Says Jan 19 2017
How Gold Soared to $1,200 on Rising Uncertainty Jan 17 2017
BlackRock: Too Big To Grow? Jan 17 2017
Lies or banter? Ex-Jefferies trader's fate lies with jury Jan 13 2017
Fund Flows: A Bad December For Active Funds; 5th Worst Month On Record Jan 13 2017
ALLIANCEBERNSTEIN HOLDING L.P. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements... Jan 12 2017
AB Announces December 31, 2016 Assets Under Management Jan 11 2017
AB Celebrates 50th Anniversary Jan 09 2017
AB Science announces publication in The Lancet of phase 3 clinical trial results demonstrating... Jan 09 2017
AllianceBernstein Holding LP : AB-US: Dividend Analysis : November 07th, 2016 (record date) : By the... Jan 06 2017
AB's Zlotnikov Warns of U.S. Recession in 2018 Jan 06 2017
Ex-Jefferies trader lied to customers, jurors are told Jan 05 2017
Placing Your Bets in the 2017 Trump Trade Jan 04 2017
Placing Your Bets in the 2017 Trump Trade Jan 04 2017
U.S. stocks riding a bull market in corruption Jan 04 2017
New preclinical data demonstrate that masitinib has an unexpected protective effect on muscles and... Jan 03 2017
AB Science announces that new preclinical data demonstrate that masitinib has an unexpected... Jan 03 2017
Distenfeld: Risk Markets Are Ahead of Themselves Dec 22 2016
AllianceBernstein downgraded by BofA/Merrill Dec 16 2016
Masters: Harder to Capture True U.S. Productivity Dec 16 2016
Seth Masters: We're Overweight Non-U.S. Equities Dec 16 2016
Seth Masters: Bull Market Lacks Paranoia of 2012 Dec 16 2016
ALLIANCEBERNSTEIN HOLDING L.P. Files SEC form 8-K, Other Events Dec 15 2016
AB Announces October 31, 2016 Assets Under Management Nov 09 2016
AllianceBernstein Holding L.P. Announces Third Quarter Results Oct 26 2016
AB Announces September 30, 2016 Assets Under Management Oct 11 2016
Filing of masitinib in the treatment of amyotrophic lateral sclerosis to the European Medicine... Sep 29 2016
AB Announces August 31, 2016 Assets Under Management Sep 12 2016
Masitinib Receives from EMA Orphan Drug Designation in the European Union for Amyotrophic Lateral... Aug 08 2016
AllianceBernstein Holding L.P. Announces Second Quarter Results Jul 28 2016
AB Statement On Visium Transaction Jul 28 2016
AB to Report Second Quarter 2016 Results on Thursday, July 28, 2016 Jul 14 2016
FDA approves first compassionate use of masitinib in amyotrophic lateral sclerosis Jul 11 2016
AB Science announces the announces the publication of preclinical study results with masitinib in... Jul 11 2016
Review of the conditional marketing authorization application of masitinib in amyotrophic lateral... Jul 04 2016
AB Science is holding an Investor & Analyst conference in New York on June 13, 2016 on masitinib in... Jun 22 2016
AB Announces May 31, 2016 Assets Under Management Jun 09 2016
AB Science announces that Rapporteurs appointed by the EMA have recommended the filing of masitinib... Jun 06 2016
AB Announces April 30, 2016 Assets Under Management May 10 2016
AB Science has submitted to EMA the marketing authorization application for Masitinib in the... May 02 2016
Choice Hotels International Signs Master Development Agreement To Enter Middle East Apr 28 2016
AllianceBernstein Holding L.P. Announces First Quarter Results Apr 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)